Search for: "The Industry Promotion FundĀ " Results 2901 - 2920 of 4,879
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2023, 9:01 pm by renholding
The SEC’s examinations program will continue to focus on uncovering key risks and violations that could impact individual investors, from cybersecurity to private fund adviser conflicts of interest. 1.2 Enhance the use of market and industry data, particularly to prevent, detect, and enforce against improper behavior. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
30 May 2012, 1:37 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
22 Jun 2011, 7:09 am by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
15 Feb 2012, 7:42 am by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
11 Feb 2011, 7:51 am by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
9 Sep 2011, 8:40 am by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
2 Oct 2010, 8:43 am by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales.CLIENT LIST• SPEECHES (not complete list): National Venture Capital Association, U.S. [read post]
5 Jun 2014, 12:14 pm
  But it’s clear to us that the FDA is on the wrong side of history here, and sooner or later its meat-axe approach to off-label promotion will fall before the Constitution’s guarantee of free speech. [read post]
9 Aug 2019, 7:33 am by Rebecca Tushnet
” The court found that this statement was sufficiently pled to be “commercial advertising or promotion. [read post]
28 Mar 2021, 7:01 am by Jessica Brandt
And it uses state control over key players in China’s technology industry to facilitate surveillance and undermine privacy. [read post]
22 Jan 2023, 9:01 pm by renholding
On May 25, 2022, the SEC also proposed amendments to Rule 35d‑1 under the Investment Company Act of 1940 (the “Names Rule”), which currently generally requires that if a fund’s name indicates a focus on a particular type of investment, or investments in a particular industry, or geographic region, the fund must adopt a policy to invest at least 80% of the value of its assets in the type of investment, or investments in the industry or… [read post]
11 Oct 2021, 11:10 am by Emily Dai
The event will feature Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria; and Julie Gerberding, executive vice president and chief patient officer at Merck & Co., Inc. [read post]
24 Mar 2010, 3:17 pm by Adam Thierer
By Adam Thierer & Berin Szoka As we mentioned yesterday, in a new series of essays, we will be examining proposals being put forward today that would have the government play a greater role in sustaining struggling media enterprises, “saving journalism,” or promoting more “public interest” content. [read post]
22 Sep 2024, 9:10 pm
However, with the risks of doing business mounting and therewards seemingly decreasing,1&2 many investors are now confronted with the reality that the problemsthey are facing in the China market may be permanent features that require a substantial strategic rethink.The central concern for European Chamber members is China’s economic slowdown. 3 However, severalother factors are dragging on business confidence, including perennial market access and regulatorybarriers; a highly politicised… [read post]